Presentation Information
[DGP3-04]DG2025-84: ICH M12 Guideline for Drug interaction studies - Deployment in Bioanalysis -
*Mizuki Horiuchi1, Takashige Okayama2, Yukari Kamikozawa3, Hiromi Sawada4, Kazuya Takano5, Kosuke Fukuda6, Shiori Honda7, Eriko Matsui8, Ryosuke Ide3 (1. Pfizer R&D Japan G.K., 2. Taiho Pharmaceutical Co., Ltd., 3. Tanabe Pharma Corporation, 4. Shionogi & Co., Ltd., 5. Sunplanet Co., Ltd., 6. Sumitomo Pharma Co., Ltd., 7. Kaken Pharmaceutical Co., Ltd., 8. CMIC Pharma Science Co., Ltd.)
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in